Evidence map›Paper›PMID 41772162›Full record

ArticleZeitschrift fur Rheumatologie2026

[Quality management in the rheumatology laboratory].

Jochen Veigel, Ulrich Sack

Abstract readEnglish Abstract
PubMed Publisher
In one paragraph

Article in Zeitschrift fur Rheumatologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jochen VeigelMVZ Labor Dr. Reising-Ackermann und Kollegen GbR, Strümpellstraße 40, 04289, Leipzig, Deutschland.
Ulrich SackInstitut für Klinische Immunologie, Universitätsklinikum Leipzig, Johannisallee 30, 04103, Leipzig, Deutschland. ulrich.sack@medizin.uni-leipzig.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Laboratory diagnostic tests in rheumatology laboratories are subject to the regulations of the German Medical Association, whose guidelines on quality assurance for laboratory medical examinations (Rili-BÄK) are binding. Quality assurance covers the entire process-from sample collection, transport, and distribution to analysis and diagnosis. We present examples of typical procedures in the rheumatology laboratory and discuss key aspects of quality assurance. The laboratory diagnostic procedures used should comprise CE-marked in vitro diagnostic devices. The introduction of tests into the laboratory requires clinical evidence of the validity of the tests. In addition, the procedures must be verified/validated, performed under quality control, and evaluated in a meaningful way. Participation in laboratory comparisons ensures correct implementation. The article concludes with information on professional law and reimbursement issues.

Indexed as

Clinical Laboratory TechniquesQuality Assurance, Health CareRheumatic DiseasesRheumatologyGermanyHumansPractice Guidelines as TopicTotal Quality ManagementAutoantibodiesGuidelinesQuality controlRheumatologyValidation

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.